| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/15/2010 | US20100095399 Protein for use in modifying abiotic stress tolerance in yeast |
| 04/15/2010 | US20100095398 Protection against environmental toxicity through manipulation of the processing of messenger RNA precursors |
| 04/15/2010 | US20100095397 Polynucleotides and methods for the improvement of plants |
| 04/15/2010 | US20100095390 Aldolases, Nucleic Acids Encoding Them and Methods for Making and Using Them |
| 04/15/2010 | US20100093989 Methods For Production And Purification Of Nucleic Acid Molecules |
| 04/15/2010 | US20100093988 Nucleic acid encoding receptor type protein kinase |
| 04/15/2010 | US20100093987 Inhibitor Nucleic Acids |
| 04/15/2010 | US20100093841 Cell culture system of a hepatitis c genotype 3a and 2a chimera |
| 04/15/2010 | US20100093839 hypoxia-inducible factor-1 alpha (HIP-1 alpha); nucleosides, Locked Nucleic Acids; treating kidney cancer, melanoma, glioblastoma and prostate cancer, and pre-eclampsia |
| 04/15/2010 | US20100093838 Regulation of angiogenesis with zinc finger proteins |
| 04/15/2010 | US20100093837 Microrna molecules |
| 04/15/2010 | US20100093833 Methods for Inducing Differentiation of Undifferentiated Mammalian Cells Into Osteoblasts |
| 04/15/2010 | US20100093831 Nucleic acid compounds for inhibiting angiogenesis and tumor growth |
| 04/15/2010 | US20100093830 Modulation of MLCK-L Expression and Uses Thereof |
| 04/15/2010 | US20100093642 Novel polypeptides |
| 04/15/2010 | US20100093633 Polypeptides having antimicrobial activity |
| 04/15/2010 | US20100093630 Mammalian chemokines; related reagents |
| 04/15/2010 | US20100093628 Methods of treatment using wisp polypeptides |
| 04/15/2010 | US20100093627 Albumin fusion proteins |
| 04/15/2010 | US20100093617 Use |
| 04/15/2010 | US20100093608 Modified animal erythropoietin polypeptides and their uses |
| 04/15/2010 | US20100093600 Regulation of neurotransmitters sequestration and release through manipulation of the vesicular functions |
| 04/15/2010 | US20100093563 Methods and vectors for display of molecules and displayed molecules and collections |
| 04/15/2010 | US20100093095 Compositions and methods for enhanced bacterial exopolysaccharide production |
| 04/15/2010 | US20100093094 Triazine dendrimers and methods of making and using the same for nucleic acid transport |
| 04/15/2010 | US20100093085 Tripartite oligonucleotide complexes and methods for gene silencing by rna interference |
| 04/15/2010 | US20100093076 Soluble il-27 receptor |
| 04/15/2010 | US20100093068 System and methods for nucleic acid sequencing of single molecules by polymerase synthesis |
| 04/15/2010 | US20100093062 Transfection system for perkinsus species |
| 04/15/2010 | US20100093058 High Transgene Expression Of A Pseudotyped Adeno-Associated Virus Type |
| 04/15/2010 | US20100093045 L-cysteine producing microorganism and a method for producing l-cysteine |
| 04/15/2010 | US20100093043 Biological Systems for Manufacture of Polyhydroxyalkanoate Polymers Containing 4-Hydroxyacids |
| 04/15/2010 | US20100093040 Modified beta-glucosidases with improved stability |
| 04/15/2010 | US20100093039 Cell Culture Media for Enhanced Protein Production |
| 04/15/2010 | US20100093036 Novel Vectors for Production of Growth Hormone |
| 04/15/2010 | US20100093035 Novel streptococcus antigens |
| 04/15/2010 | US20100093034 Alkaline Bacillus Amylase |
| 04/15/2010 | US20100093031 Dna encoding xylitol dehydrogenase |
| 04/15/2010 | US20100093030 Production of secreted proteins by filamentous fungi |
| 04/15/2010 | US20100093029 Modified luciola cruciata luciferase gene and protein |
| 04/15/2010 | US20100093028 Modified variant bowman birk protease inhibitors |
| 04/15/2010 | US20100093027 3-phosphoinositide-dependent protein kinase that phosphorylates and activates protein kinase B alpha; drug target for cancer; drug screening for enzyme inhibitors as anticancer agents |
| 04/15/2010 | US20100093018 Cells expressing chimeric proteins and assays using such cells |
| 04/15/2010 | US20100093017 Metabolically Competent Cell Lines |
| 04/15/2010 | US20100092998 Methods and compositions relating to e3 ring-e2 fusion proteins |
| 04/15/2010 | US20100092990 Nucleic acids encoding sodium channel scn1a alpha subunit proteins and mutations associated with epilepsy |
| 04/15/2010 | US20100092976 Thermostable duplex-specific nuclease |
| 04/15/2010 | US20100092975 Use of novel cytokine receptors as biomarkers and therapeutic targets in human cancer |
| 04/15/2010 | US20100092968 Method and Means for Enrichment, Removal and Detection of Gram-Positive Bacteria |
| 04/15/2010 | US20100092948 Biological bar code |
| 04/15/2010 | US20100092943 Screening method with the use of tbk1 knockout mouse |
| 04/15/2010 | US20100092941 32142,21481,25964,21686, Novel dehydrogenase molecules and uses therefor |
| 04/15/2010 | US20100092613 Cloning and expression of a novel phytase |
| 04/15/2010 | US20100092606 Maize nucleotide sequence coding for a protein with transglutaminase activity and use thereof |
| 04/15/2010 | US20100092572 Chitosan-based colloidal particles for rna delivery |
| 04/15/2010 | US20100092522 Immunogenic wt-1 peptides and methods of use thereof |
| 04/15/2010 | US20100092520 Recombinant Plasmodium Falciparum Merozoite Surface Proteins 4 and 5 and Their Use |
| 04/15/2010 | US20100092518 Recombinant Intracellular Pathogen Immunogenic Compositions and Methods of Use |
| 04/15/2010 | US20100092513 Methods and compositions for inducing an immune response to HIV and models for testing |
| 04/15/2010 | US20100092502 Modified hiv env polypeptides |
| 04/15/2010 | US20100092494 Composition and method for facilitating the internalization of a therapeutic agent into a cell |
| 04/15/2010 | US20100092491 Anti-epcam antibody and uses thereof |
| 04/15/2010 | US20100092484 Cd44 antibodies |
| 04/15/2010 | US20100092481 Human cytomegalovirus neutralising antibodies and use thereof |
| 04/15/2010 | US20100092477 Methods and compositions for treating prostate cancer |
| 04/15/2010 | US20100092455 Novel anti-proliferation antibodies |
| 04/15/2010 | US20100092449 Treatment of Pompe's Disease |
| 04/15/2010 | US20100092438 Bacteria Mediated Gene Silencing |
| 04/15/2010 | US20100092437 Radiation inducible promoter |
| 04/15/2010 | US20100092434 Thrombopoietic activity of tyrosyl-trna synthetase polypeptides |
| 04/15/2010 | US20100092431 Edwardsiella Ictaluri Bacteriophage and Uses Thereof |
| 04/15/2010 | DE102008050860A1 LCMV-GP-VSV-Pseudotypvektoren und tumorinfiltrierende Virenproduzentenzellen zur Therapie von Tumoren LCMV-GP-VSV pseudotype vectors and tumor-infiltrating virus producer cells for the therapy of tumors |
| 04/15/2010 | CA2739971A1 Il-17-mediated transfection methods |
| 04/15/2010 | CA2739948A1 Treating hepatitis c virus infection with over-expression of microrna-196 |
| 04/15/2010 | CA2739902A1 Engineered cells expressing multiple immunomodulators and uses thereof |
| 04/15/2010 | CA2739881A1 Novel fructosyl peptide oxidase |
| 04/15/2010 | CA2739608A1 Recombinant nell protein production |
| 04/15/2010 | CA2738557A1 Process of clean cloning |
| 04/15/2010 | CA2733262A1 Antisense oligonucleotides directed against connective tissue growth factor and uses thereof |
| 04/14/2010 | EP2175391A2 Mutation detection and identification |
| 04/14/2010 | EP2175271A1 Test method on feline vaccinated with feline immunodeficiency virus vaccine, and antigen for use in the test |
| 04/14/2010 | EP2175035A1 Method for obtaining information on biological rhythm by using hair |
| 04/14/2010 | EP2175029A1 Lactic acid production method |
| 04/14/2010 | EP2175028A2 Phosphatase stress-related proteins and methods of use in plants |
| 04/14/2010 | EP2175027A2 Reduced susceptibility towards pathogens, in particular oomycetes, such as downy mildew in lettuce and spinach |
| 04/14/2010 | EP2175026A1 Stress resistant plants |
| 04/14/2010 | EP2175025A1 Process for producing isoprenoid compounds by using microorganisms |
| 04/14/2010 | EP2175023A1 Anti-tumor activity of small double-stranded oligodeoxynucleotides targeting telomerase RNA |
| 04/14/2010 | EP2175022A1 Methods of construction biodiverse gene fragment libraries |
| 04/14/2010 | EP2175021A2 Method for producing polymers |
| 04/14/2010 | EP2175020A1 Reduction of RNase activity in complex fluidic samples |
| 04/14/2010 | EP2175019A2 Quasirandom structure and function guided synthesis methods |
| 04/14/2010 | EP2175018A1 Process of clean cloning |
| 04/14/2010 | EP2175017A1 Pseudomonas aeruginosa outer membrane protein pa4710 |
| 04/14/2010 | EP2175016A1 Anti-prominin-1 antibody having adcc activity or cdc activity |
| 04/14/2010 | EP2175013A1 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
| 04/14/2010 | EP2174958A1 Antibodies derived from anti ed-b l19 and targeting tumor vasculature |
| 04/14/2010 | EP2174957A1 Monoclonal antibodies binding to avian influenza virus subtype h5 haemagglutinin and uses thereof |
| 04/14/2010 | EP2174955A1 Ifnar2 muteins, their production and use |
| 04/14/2010 | EP2174954A1 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |